Conduit Pharmaceuticals (CDT) Insider Trading & Ownership $3.48 -0.63 (-15.33%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$3.57 +0.09 (+2.61%) As of 05/23/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Conduit Pharmaceuticals (NASDAQ:CDT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage30.93%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$1.44 M Get CDT Insider Trade Alerts Want to know when executives and insiders are buying or selling Conduit Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CDT Insider Buying and Selling by Quarter Conduit Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/7/2024Ltd NirlandMajor ShareholderSell626$150.00$93,900.00 10/4/2024Ltd NirlandMajor ShareholderSell912$150.00$136,800.00 10/2/2024Ltd NirlandMajor ShareholderSell222$150.00$33,300.00 9/30/2024Ltd NirlandMajor ShareholderSell677$180.00$121,860.00 7/17/2024Andrew ReganDirectorSell1,009$390.00$393,510.00 7/15/2024Andrew ReganDirectorSell670$375.00$251,250.00 7/12/2024Andrew ReganDirectorSell926$375.00$347,250.00 7/10/2024Andrew ReganDirectorSell100$495.00$49,500.00 7/8/2024Andrew ReganDirectorSell23$765.00$17,595.00 7/3/2024Andrew ReganDirectorSell0$960.00$0.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. (Data available from 1/1/2013 forward) CDT Insider Trading Activity - Frequently Asked Questions Who is on Conduit Pharmaceuticals's Insider Roster? The list of insiders at Conduit Pharmaceuticals includes Andrew Regan, and Ltd Nirland. Learn more on insiders at CDT. What percentage of Conduit Pharmaceuticals stock is owned by insiders? 30.93% of Conduit Pharmaceuticals stock is owned by insiders. Learn more on CDT's insider holdings. Which Conduit Pharmaceuticals insiders have been selling company stock? The following insiders have sold CDT shares in the last 24 months: Andrew Regan ($1,059,105.00), and Ltd Nirland ($385,860.00). How much insider selling is happening at Conduit Pharmaceuticals? Insiders have sold a total of 5,165 Conduit Pharmaceuticals shares in the last 24 months for a total of $1,444,965.00 sold. Conduit Pharmaceuticals Key ExecutivesDr. David Joszef Tapolczay (Age 65)CEO & Director Compensation: $419.8kMr. Adam Sragovicz (Age 54)Chief Financial Officer Compensation: $116.67kDr. Joanne M. Holland (Age 49)Chief Scientific Officer More Insider Trading Tools from MarketBeat Related Companies TherapeuticsMD Insider Selling X4 Pharmaceuticals Insider Selling Relmada Therapeutics Insider Selling GlycoMimetics Insider Selling Bullfrog AI Insider Selling ProMIS Neurosciences Insider Selling Cingulate Insider Selling GeoVax Labs Insider Selling Rallybio Insider Selling Eterna Therapeutics Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Turbulence for Joby Shares: What's Behind the Recent Dip?UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market Cap This page (NASDAQ:CDT) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredThe “black glass” breakthrough behind AI’s next leapAI is advancing fast… But there’s one problem almost no one’s talking about. Power.True Market Insiders | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Conduit Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Conduit Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CDT Stock Free CDT Stock Alerts